Mammalian sex determination is a dynamic process involving balanced gene expression leading to the development of either a testis or an ovary. Candidate sex-determining genes have been identified through microarray-based studies of gonadal gene expression; however, few methods exist for validation. This study describes a new technique for transfecting gonads using nucleofection. Fifteen micrograms of expression plasmid DNA was transfected into E11.5 gonads, cultured for 3 days and gene expression analyzed. Following optimization, we consistently achieved cell transfection efficiencies of 11% of cells using pMax-GFP plasmid. To test the applicability of nucleofection to studies of gene function, a testis-determining gene was transfected into gonads and its ability to sex-reverse was examined. When Sry was transfected into female (XX) gonads, upregulation of its target gene Sox9 was observed, as well as a downregulation of the ovarian gene Foxl2. Conversely, when shSox9 was introduced into male (XY) gonads, reduction of Sox9 and its target gene, Amh was observed, with a concomitant upregulation of Foxl2. Nucleofection-based gene delivery can recapitulate in vivo events of gonadal development that demonstrates ‘proof-of-principle’ of the method as a screening tool to evaluate the cellular function of potential sex-determining and gonadal differentiation genes.

Keywords:
DNA delivery, Nucleofection, Organ culture, Sex determination, SOX9, SRY gonads
1.
Bagheri-Fam S, Sim H, Bernard P, Jayakody I, Taketo MM, Scherer G, Harley VR: Loss of Fgfr2 leads to partial XY sex reversal. Dev Biol 314:71–83 (2008).
2.
Barrionuevo F, Bagheri-Fam S, Klattig J, Kist R, Taketo MM, Englert C, Scherer G: Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol Reprod 74:195–201 (2006).
3.
Behringer RR, Finegold MJ, Cate RL: Mullerian-inhibiting substance function during mammalian sexual development. Cell 79:415–425 (1994).
4.
Bernard P, Sim H, Knower K, Vilain E, Harley V: Human SRY inhibits beta-catenin-mediated transcription. Int J Biochem Cell Biol 40:2889–2900 (2008).
5.
Chassot AA, Ranc F, Gregoire EP, Roepers-Gajadien HL, Taketo MM, et al: Activation of beta-catenin signaling by RSPO1 controls differentiation of the mammalian ovary. Hum Mol Genet 17:1264–1277 (2008).
6.
Coveney D, Cool J, Oliver T, Capel B: Four-dimensional analysis of vascularization during primary development of an organ, the gonad. Proc Natl Acad Sci U S A 105:7212–7217 (2008).
7.
Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al: The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159–166 (2001).
8.
De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, et al: Direct Interaction of SRY-Related Protein SOX9 and Steroidogenic Factor 1 Regulates Transcription of the Human Anti-Müllerian Hormone Gene. Mol Cell Biol 18:6653-6665 (1998).
9.
Forbes K, Desforges M, Garside R, Aplin JD, Westwood M: Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta 30:124–129 (2009).
10.
Hersmus R, de Leeuw BH, Stoop H, Bernard P, van Doorn HC, et al: A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma. Eur J Hum Genet 17:1642–1649 (2009).
11.
Hughes IA, Houk C, Ahmed SF, Lee PA: Consensus statement on management of intersex disorders. J Pediatr Urol 2:148–162 (2006).
12.
Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, et al: FGF9 and WNT4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187 (2006).
13.
Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R: Male development of chromosomally female mice transgenic for Sry. Nature 351:117–121 (1991).
14.
Lau YF, Li Y: The human and mouse sex-determining SRY genes repress the Rspol/beta-catenin signaling. J Genet Genomics 36:193–202 (2009).
15.
Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B: Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 17:2949–2955 (2008).
16.
Malki S, Nef S, Notarnicola C, Thevenet L, Gasca S, et al: Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J 24:1798–1809 (2005).
17.
Martineau J, Nordqvist K, Tilmann C, Lovell-Badge R, Capel B: Male-specific cell migration into the developing gonad. Curr Biol 7:958–968 (1997).
18.
McLaren A, Buehr M: Development of mouse germ cells in cultures of fetal gonads. Cell Differ Dev 31:185–195 (1990).
19.
Meachem SJ, Ruwanpura SM, Ziolkowski J, Ague JM, Skinner MK, Loveland KL: Developmentally distinct in vivo effects of FSH on proliferation and apoptosis during testis maturation. J Endocrinol 186:429–446 (2005).
20.
Merchant-Larios H, Moreno-Mendoza N, Buehr M: The role of the mesonephros in cell differentiation and morphogenesis of the mouse fetal testis. Int J Dev Biol 37:407–415 (1993).
21.
Merkerova M, Klamova H, Brdicka R, Bruchova H: Targeting of gene expression by siRNA in CML primary cells. Mol Biol Rep 34:27–33 (2007).
22.
Nakamura Y, Yamamoto M, Matsui Y: Introduction and expression of foreign genes in cultured mouse embryonic gonads by electroporation. Reprod Fertil Dev 14:259–265 (2002).
23.
Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, et al: Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053–2062 (2005).
24.
Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, et al: Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16:2795–2804 (2007).
25.
Palmer SJ, Burgoyne PS: In situ analysis of fetal, prepuberal and adult XX–XY chimaeric mouse testes: Sertoli cells are predominantly, but not exclusively, XY. Development 112:265–268 (1991).
26.
Ross AJ, Capel B: Signaling at the crossroads of gonad development. Trends Endocrinol Metab 16:19–25 (2005).
27.
Ross AJ, Tilman C, Yao H, MacLaughlin D, Capel B: AMH induces mesonephric cell migration in XX gonads. Mol Cell Endocrinol 211:1–7 (2003).
28.
Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B: Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 131:3627–3636 (2004).
29.
Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M: The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933–942 (2004).
30.
Seiffert M, Stilgenbauer S, Dohner H, Lichter P: Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 21:1977–1983 (2007).
31.
Sekido R, Lovell-Badge R: Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930–934 (2008).
32.
Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, et al: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240–244 (1990).
33.
Svingen T, Wilhelm D, Combes AN, Hosking B, Harley VR, Sinclair AH, Koopman P: Ex vivo magnetofection: A novel strategy for the study of gene function in mouse organogenesis. Dev Dyn 238:956–964 (2009).
34.
Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, et al: Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139:1130–1142 (2009).
35.
Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combes AN, et al: Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol 287:111–124 (2005).
36.
Wilhelm D, Hiramatsu R, Mizusaki H, Widjaja L, Combes AN, Kanai Y, Koopman P: SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. J Biol Chem 282:10553–10560 (2007).
37.
Wilhelm D, Washburn LL, Truong V, Fellous M, Eicher EM, Koopman P: Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice. Mech Dev 126:324–336 (2009).
38.
Xiao WL, Shi B, Zheng Q, Wang Y, Huang L, et al: Nucleofection is highly efficient for transfecting genes into murine embryonic palatal mesenchymal cells in primary culture. Int J Oral Maxillofac Surg 36:429–434 (2007).
39.
Zaragosi LE, Billon N, Ailhaud G, Dani C: Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 25:790–797 (2007).
40.
Zeitelhofer M, Vessey JP, Xie Y, Tubing F, Thomas S, Kiebler M, Dahm R: High-efficiency transfection of mammalian neurons via nucleofection. Nat Protoc 2:1692–1704 (2007).
41.
Zheng W, Izaki J, Furusawa S, Yoshimura Y: A sensitive non-radioactive in situ hybridization method for the detection of chicken IgG gamma-chain mRNA: A technique suitable for detecting of variety of mRNAs in tissue sections. Biol Proced Online 3:1–7 (2001).
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.